Targeting defective proteostasis in the collagenopathies

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Collagenopathies are genetic disorders caused by mutations in collagen genes.
• These mutations disrupt collagen production and integrity, leading to impaired development and connective tissue damage.
• Current treatments for collagenopathies primarily manage symptoms, lacking targeted approaches for the underlying molecular defects.

Purpose of the Study:

• To present a proteostasis-focused perspective on collagenopathies.
• To highlight how collagen proteostasis mechanisms are disrupted in these diseases.
• To explore the potential of small molecule therapeutics for endoplasmic reticulum proteostasis in treating collagenopathies.

Main Methods:

• Review of existing literature on collagenopathies and proteostasis.
• Analysis of molecular mechanisms underlying collagen biosynthesis and quality control.
• Examination of recent advances in small molecule modulators of endoplasmic reticulum proteostasis.

Main Results:

• Disruptions in collagen biogenesis due to genetic mutations are central to collagenopathies.
• The intracellular proteostasis network is a viable target for therapeutic intervention.
• Small molecules targeting endoplasmic reticulum proteostasis show potential for treating these disorders.

Conclusions:

• Resculpting the proteostasis network offers a novel therapeutic avenue for collagenopathies.
• Understanding disease-specific proteostasis disruptions is key to developing effective treatments.
• Small molecule-based modulation of endoplasmic reticulum proteostasis presents a promising strategy for future therapies.